The article prepared by MecNano Technologies team has been published by one of the world's largest publishers Elsevier's journal "Journal of Drug Delivery Science and Technology (Impact factor: 5.1)".

In this study entitled ''In Vitro and in Vivo Evaluation of Multi-Target-Directed Rivastigmine/Memantine/Gingko Biloba-Loaded Nanofibers Against Alzheimer's Disease'', rivastigmine, memantine, and Ginkgo biloba, which were combined for the treatment of Alzheimer's disease, were loaded into nanofibers, which are a drug delivery system in nano-scale, suitable for the sublingual application, an alternative drug administration route, and its biological activity was examined with cell culture and animal studies. The bioavailability was increased to 100% by reducing the drug administration dose. Congratulations to the staff of MecNano Technologies and all authors who contributed to the article.